Motus GI today priced its upcoming initial public offering, dropping the range from a midpoint of $26 million to a total of $18 million.
In the offering, the Fort Lauderdale, Fla.-based company said it will offer 3.5 million shares of common stock at $5 per share, with its shares slated to begin trading on Nasdaq today under the ticker symbol “MOTS”.
The company developed and produces the Pure-Vu cleaning system which is designed to be used with a standard colonoscope to perform intra-procedural cleaning of poorly prepared colons.
Piper Jaffray & Co. is acting as sole book-running manager with Oppenheimer & Co. acting as lead manager for the offering, the company said in a press release.
On June 4-5, DeviceTalks is taking over the Twin Cities medtech industry with one of the most anticipated conferences of the spring, bringing you the best and brightest minds in the industry.
Heidi Dohse: Sr. Program Manager, Healthcare, Google, Founder, Tour de Heart Foundation, Acessa Health Inc. Michael J. Pederson: Senior Vice President, Cardiac Arrhythmias and Heart Failure Division, Abbott Hon. Melvin Carter: Mayor, Saint Paul Tim Philips: Compliance Officer, FDA’s Office of Medical Device and Radiological Health Operations Dr. Myriam J. Curet, MD, FACS: Chief Medical Officer, Intuitive Surgical
Take a look at our incredible line up of speakers and join us now.
Use the code "KEYNOTE" to save 15% on the cost of registration.